Three-Dimensional (3D) Microtissues: Organoids and Spheroids

We establish organoids from stem cells and spheroids from (tumor) cell lines as multicellular 3D in-vitro microtissues. These mimic the microenvironment of cells including the specific morphological and physiological properties of complex tissues and organs. 

Mikroskopische Aufnahme eines Darm-Organoids
© Fraunhofer IGB
Microscopic image of an intestinal organoid

Organoids

An organoid is a self-organized 3D tissue that is usually derived from pluripotent, fetal or adult stem cells and mimics the essential functional, structural and biological complexity of an organ. This self-organization is specifically controlled by signaling molecules, growth factors and biological stimuli. Compared to conventional 2D cultures and animal models, organoid cultures allow for patient specificity in the model while recapitulating in-vivo tissue-like structures and functions in vitro. 

Mikroskopische Aufnahme eines Fibroblasten-Sphäroids
© Fraunhofer IGB
Microscopic image of a fibroblast spheroid

Spheroids

are formed as simple, spherical 3D cell aggregates from just one cell type or a multicellular cell mixture using defined cultivation methods. Based on cancer cell lines, so-called tumoroids can also be formed, which resemble solid tumors. 

Next-generation test systems for research, drug development and medicine

For decades, mammalian 2D cell cultures have been used as simple in-vitro test systems for substance testing and screening for new compounds in drug development. Organoids, however, are the “next generation” of biological tools for research, drug development and medicine. Due to their complex tissue and organ-like properties, they represent the in-vivo situation and are particularly suitable for use in translational research.

Our development: organoids and spheroids of varying complexity

With our decades of expertise in cell culture technology and the handling of (pathogenic) microorganisms as well as working to the highest quality standards, we develop organoids and spheroids of varying complexity. Depending on the application, the 3D microtissues can also contain immune cells, microorganisms and reporter systems for detecting the activation of a cellular signaling pathway.

Organoidmodelle
© Fraunhofer IGB
Organoidmodelle (erstellt mit BioRender.com).
 

Reporter spheroids

We establish reporter spheroids to detect the activation of cellular signaling pathways. These spheroids are well suited, for example, to be used in microfluidic systems for sensor-monitored real-time analysis of in-vitro cell and tissue cultures.

 

Intestinal organoids

We establish complex intestinal organoids from stem cells as multicellular 3D in-vitro microtissues, including inside-out intestinal organoids using a special culture method. The microtissues are suitable for investigating the properties of substances that are toxic to the intestine, for examining immune responses, host-microbiota interactions, the effects of prebiotics and probiotics, and the mechanisms of action of drugs against intestinal diseases.

Our portfolio of organoids and spheroids

We provide specifically suitable 3D microtissues for different questions and applications:

  • Human and animal 3D microtissues
  • Reporter spheroids for non-invasive real-time detection of the activation of cellular signaling pathways
  • Immunocompetent organoids
  • Organoids for the investigation of microbiomes and infections with bacteria, fungi and viruses

Applications of spheroids and organoids

3D microtissues from human (stem) cells have important applications in biomedical research, as they are far superior to animal experiments in terms of their predictive value. The use of 3D microtissues as human in-vitro test systems enables 

The use of 3D microtissues as human in-vitro test systems enables 

  • Higher throughput (using special microtiter plates for cultivating spheroids and a unique 3D incubator and reactor for cultivating organoids),
  • A deeper understanding of mechanisms of action by studying specific heterogeneous cell populations, intrinsic histological structures and the communication between cells and the surrounding extracellular matrix,
  • Genomic, epigenomic, pharmacological and biochemical studies and
  • A deeper understanding of the development of organs, diseases and the development of cancer,
  • The risk assessment of substances according to the concept of Adverse Outcome Pathways (AOP).

We provide a broad portfolio of 3D microtissues as in-vitro test systems for various applications to assess the efficacy and safety of drugs and chemicals, for

  • Determination of toxicity,
  • Analysis of transport processes and absorption of a substance,
  • Development and preclinical testing of active ingredients and
  • Investigation of the activation of cellular signaling pathways (sensitization, inflammation, ER stress)

Range of services

We offer the following services relating to our 3D microtissues, which we carry out in state-of-the-art laboratories on behalf of and in collaboration with customers:

  • Conducting studies and substance screenings
  • Development of innovative (reporter) spheroids
  • Development of complex organoids 

Analysis methods

In our 3D microtissues, the effects of chemicals, active substances and products on the architecture of the tissue and physiological properties can be investigated. We offer the following analysis methods:

  • Vitality measurements, for example using the MTT test (colorimetric test), alamarBlue(TM)
  • Multiplex analysis for the detection and quantification of secreted proteins such as cytokines, chemokines, growth factors and antimicrobial peptides
  • Histological and immunohistochemical staining of tissue thin sections
  • Protein analyses using Western blot
  • Analysis of specific signaling pathway activation via reporter proteins
  • RNA and DNA analyses using PCR or qPCR and sequencing